A human laboratory study investigating the effects of quetiapine on marijuana withdrawal and relapse in daily marijuana smokers

Addiction Biology

Volumn 18, Issue 6, 2013, Pages 993-1002

  Cooper, Ziva D ^a   Foltin, Richard W ^a   Hart, Carl L ^a   Vosburg, Suzanne K ^a   Comer, Sandra D ^a   Haney, Margaret ^a  

^a Columbia University ^*  (United States)

Author keywords

Marijuana; relapse; withdrawal

Indexed keywords

CANNABIS; DRONABINOL; PLACEBO; QUETIAPINE; RIBOFLAVIN;

ADULT; ALCOHOLIC BEVERAGE; APPETITE; ARTICLE; ATTENTION; CALORIC INTAKE; CANNABIS SMOKING; CLINICAL ARTICLE; CONTROLLED STUDY; DEMOGRAPHY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG SEEKING BEHAVIOR; DRUG SELF ADMINISTRATION; FEMALE; FOOD INTAKE; HUMAN; LEARNING; MALE; MEMORY; MOOD; PRIORITY JOURNAL; PSYCHOMOTOR ACTIVITY; PSYCHOMOTOR DEVELOPMENT; PSYCHOMOTOR PERFORMANCE; RELAPSE; SLEEP QUALITY; TASK PERFORMANCE; URINALYSIS; VISUAL ANALOG SCALE; WEIGHT GAIN; WEIGHT REDUCTION; WITHDRAWAL SYNDROME;

MARIJUANA; RELAPSE; WITHDRAWAL;

ADULT; AFFECT; ANALYSIS OF VARIANCE; ANOREXIA; ANTIPSYCHOTIC AGENTS; DIBENZOTHIAZEPINES; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; DRONABINOL; FEMALE; HUMANS; MALE; MARIJUANA ABUSE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PLACEBOS; PSYCHOMOTOR PERFORMANCE; RECURRENCE; SELF ADMINISTRATION; SLEEP DISORDERS; SUBSTANCE WITHDRAWAL SYNDROME; WEIGHT LOSS; YOUNG ADULT;

EID: 84889256722     PISSN: 13556215     EISSN: 13691600     Source Type: Journal    
DOI: 10.1111/j.1369-1600.2012.00461.x     Document Type: Article

References (33)

1. Allsop DJ, Norberg MM, Copeland J, Fu S, Budney AJ, (2011) The cannabis withdrawal scale development: patterns and predictors of cannabis withdrawal and distress. Drug Alcohol Depend 119: 123-129.
2. Buckley PF, (2001) Broad therapeutic uses of atypical antipsychotic medications. Biol Psychiatry 50: 912-924. (Pubitemid 34020702)
3. Budney AJ, Hughes JR, Moore BA, Novy PL, (2001) Marijuana abstinence effects in marijuana smokers maintained in their home environment. Arch Gen Psychiatry 58: 917-924. (Pubitemid 32937913)
4. Budney AJ, Moore BA, Vandrey RG, Hughes JR, (2003) The time course and significance of cannabis withdrawal. J Abnorm Psychol 112: 393-402. (Pubitemid 36959365)
5. Budney AJ, Vandrey RG, Hughes JR, Thostenson JD, Bursac Z, (2008) Comparison of cannabis and tobacco withdrawal: severity and contribution to relapse. J Subst Abuse Treat 35: 362-368.
6. Carroll KM, Easton CJ, Nich C, Hunkele KA, Neavins TM, Sinha R, Ford HL, Vitolo SA, Doebrick CA, Rounsaville BJ, (2006) The use of contingency management and motivational/skills-building therapy to treat young adults with marijuana dependence. J Consult Clin Psychol 74: 955-966. (Pubitemid 44547489)
7. Cohrs S, Rodenbeck A, Guan Z, Pohlmann K, Jordan W, Meier A, Rüther E, (2004) Sleep-promoting properties of quetiapine in healthy subjects. Psychopharmacology (Berl) 174: 421-429. (Pubitemid 39044301)
8. Comer SD, Ashworth JB, Foltin RW, Johanson CE, Zacny JP, Walsh SL, (2008) The role of human self-administration procedures in the development of medications. Drug Alcohol Depend 96: 1-15.
9. Compton WM, Grant BF, Colliver JD, Glantz MD, Stinson FS, (2004) Prevalence of marijuana use disorders in the United States: 1991-1992 and 2001-2002. JAMA 291: 2114-2121. (Pubitemid 38580155)
10. Copeland J, Swift W, Roffman R, Stephens R, (2001) A randomized controlled trial of brief cognitive-behavioral interventions for cannabis use disorder. J Subst Abuse Treat 21: 55-64. discussion 65-6. (Pubitemid 32830152)
11. Foltin RW, Brady JV, Fischman MW, Emurian CS, Dominitz J, (1987) Effects of smoked marijuana on social interaction in small groups. Drug Alcohol Depend 20: 87-93.
12. Foltin RW, Fischman MW, Pippen PA, Kelly TH, (1993) Behavioral effects of cocaine alone and in combination with ethanol or marijuana in humans. Drug Alcohol Depend 32: 93-106. (Pubitemid 23131211)
13. Haney M, (2009) Self-administration of cocaine, cannabis and heroin in the human laboratory: benefits and pitfalls. Addict Biol 14: 9-21.
14. Haney M, Comer SD, Ward AS, Foltin RW, Fischman MW, (1997) Factors influencing marijuana self-administration by humans. Behav Pharmacol 8: 101-112. (Pubitemid 27303906)
15. Haney M, Hart CL, Vosburg SK, Comer SD, Reed SC, Cooper ZD, Foltin RW, (2010) Effects of baclofen and mirtazapine on a laboratory model of marijuana withdrawal and relapse. Psychopharmacology (Berl) 211: 233-244.
16. Haney M, Hart CL, Vosburg SK, Comer SD, Reed SC, Foltin RW, (2008) Effects of THC and lofexidine in a human laboratory model of marijuana withdrawal and relapse. Psychopharmacology (Berl) 197: 157-168.
17. Haney M, Hart CL, Vosburg SK, Nasser J, Bennett A, Zubaran C, Foltin RW, (2004) Marijuana withdrawal in humans: effects of oral THC or divalproex. Neuropsychopharmacology 29: 158-170. (Pubitemid 38068026)
18. Haney M, Spealman R, (2008) Controversies in translational research: drug self-administration. Psychopharmacology (Berl) 199: 403-419.
19. Haney M, Ward AS, Comer SD, Foltin RW, Fischman MW, (1999) Abstinence symptoms following smoked marijuana in humans. Psychopharmacology (Berl) 141: 395-404. (Pubitemid 29190008)
20. Hart CL, Haney M, Ward AS, Fischman MW, Foltin RW, (2002) Effects of oral THC maintenance on smoked marijuana self-administration. Drug Alcohol Depend 67: 301-309. (Pubitemid 34786265)
21. Kouri EM, Pope HG Jr, (2000) Abstinence symptoms during withdrawal from chronic marijuana use. Exp Clin Psychopharmacol 8: 483-492.
22. Kulkarni SK, Kaur G, (2001) Pharmacodynamics of drug-induced weight gain. Drugs Today (Barc) 37: 559-571. (Pubitemid 33043076)
23. Levin FR, Mariani JJ, Brooks DJ, Pavlicova M, Cheng W, Nunes EV, (2011) Dronabinol for the treatment of cannabis dependence: a randomized, double-blind, placebo-controlled trial. Drug Alcohol Depend 116: 142-150.
24. Levin KH, Copersino ML, Heishman SJ, Liu F, Kelly DL, Boggs DL, Gorelick DA, (2010) Cannabis withdrawal symptoms in non-treatment-seeking adult cannabis smokers. Drug Alcohol Depend 111: 120-127.
25. Mehmedic Z, Chandra S, Slade D, Denham H, Foster S, Patel AS, Ross SA, Khan IA, ElSohly MA, (2010) Potency trends of Δ9-THC and other cannabinoids in confiscated cannabis preparations from 1993 to 2008. J Forensic Sci 55: 1209-1217.
26. Pae CU, Sohi MS, Seo HJ, Serretti A, Patkar AA, Steffens DC, Masand PS, (2010) Quetiapine xr: current status for the treatment of major depressive disorder. Prog Neuropsychopharmacol Biol Psychiatry 34: 1165-1173.
27. Perez AY, Kirkpatrick MG, Gunderson EW, Marrone G, Silver R, Foltin RW, Hart CL, (2008) Residual effects of intranasal methamphetamine on sleep, mood, and performance. Drug Alcohol Depend 94: 258-262.
28. Potvin S, Stip E, Roy JY, (2004) The effect of quetiapine on cannabis use in 8 psychosis patients with drug dependency. Can J Psychiatry 49: 711. (Pubitemid 39524666)
29. Ramchand R, Griffin BA, Suttorp M, Harris KM, Morral A, (2011) Using a cross-study design to assess the efficacy of motivational enhancement therapy-cognitive behavioral therapy 5 (MET/CBT5) in treating adolescents with cannabis-related disorders. J Stud Alcohol Drugs 72: 380-389.
30. Stanger C, Budney AJ, Kamon JL, Thostensen J, (2009) A randomized trial of contingency management for adolescent marijuana abuse and dependence. Drug Alcohol Depend 105: 240-247.
31. Stephens RS, Roffman RA, Simpson EE, (1994) Treating adult marijuana dependence: a test of the relapse prevention model. J Consult Clin Psychol 62: 92-99. (Pubitemid 24058701)
32. Substance Abuse and Mental Health Services Administration (2011) Results from the 2010 National Survey on Drug Use and Health: Summary of National Findings. NSDUH Series H-41, HHS Publication No. (SMA) 11-4658. Rockville, MD: Substance Abuse and Mental Health Services Administration.
33. Vandrey R, Haney M, (2009) Pharmacotherapy for cannabis dependence: how close are we? CNS Drugs 23: 543-553.